Formed in 2011 by Christopher Watt and Samuel Thangiah, Life Science Integrates (LSI) brings together Senior Leaders from across the Life Sciences, including industry, academia, government and regulators; providing them with unique opportunities to be part of the conversations that set out the industry’s challenges and identify effective strategies and solutions.
Our purpose is to find novel and engaging ways to bring people together; to discuss, debate and uncover the strategic solutions to their industry’s challenges by creating environments that challenge traditional concepts and enable constructive debate around disruptive innovations, business models and supply chains to ensure that today’s ideas and concepts will become the effective therapies and diagnostics of the future. Ultimately helping to ensure that the Life Science Industry delivers the best possible outcomes for patients and carers.
Life Science Integrates has enabled the conversations that have helped shape our industry today and will set the direction for the future.
Bio Integrates Focuses on the biotech, start-up and emerging pharma sector addressing the needs of innovative companies that develop therapies of tomorrow.
MedTech Integrates Addresses the needs of the MedTech community to overcome the challenges needed to achieve a transformation of diagnostics and devices in healthcare.
PharmaTech Integrates will bring together all the parties to promote, educate and connect the sector to enhance technology adoption in the responsive manufacture of medicines both new and old.
Facilitating the translation of cutting-edge research and disruptive innovation into the adoption of Advanced Therapies, delivering improved patient outcomes and a revolution in healthcare economics.
Bringing together pharma and healthcare leaders across the Pharmaceutical pipeline to address their needs, to share insights and create debate on crucial topics that influence the future of patient outcomes.
CatSci Ltd, a scientifically-led, commercially-minded and award-winning innovation partner for medicines development was proud to host Vaughan Gething MS, Welsh Minister of Economy, at its facility in Cardiff to open a new material science laboratory.
Nanoform Finland Plc (“Nanoform”), an innovative nanoparticle medicine enabling company, and Herantis Pharma Plc (“Herantis”), focusing on disease modifying therapies for debilitating neurodegenerative diseases based on the natural body protein CDNF (Cerebral Dopamine Neurotrophic Factor), today announced that results from the Nanoform Proof of Concept (PoC) project show that the nanoforming process has been successfully applied to Herantis’ rhCDNF drug candidate.
SK pharmteco Inc (SKPT) is pleased to announce that Joyce Fitzharris, currently serving as General Manager, SK Biotek Ireland has been promoted to the office of President, SK biotek Ireland.
